Your session is about to expire
← Back to Search
Treatment for Charcot-Marie-Tooth Disease (INC-6603 Trial)
N/A
Recruiting
Led By Michael E Shy, MD
Research Sponsored by University of Iowa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Summary
The primary goal of this project is to develop and test a Charcot Marie Tooth disease (CMT) Pediatric Scale for use in evaluation in natural history CMT study.
Eligible Conditions
- Charcot-Marie-Tooth Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CMT Peds Scale Part 1: Symptoms
CMT Peds Scale Part 3: Hand dexterity
CMT Peds Scale Part 4: Hand strength
+5 moreSecondary outcome measures
Evaluate CMT Pediatric Scale (CMT Peds Scale) in CMT natural history study
Find a Location
Who is running the clinical trial?
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,362 Previous Clinical Trials
650,250 Total Patients Enrolled
7 Trials studying Charcot-Marie-Tooth Disease
19,648 Patients Enrolled for Charcot-Marie-Tooth Disease
University of RochesterOTHER
859 Previous Clinical Trials
538,203 Total Patients Enrolled
8 Trials studying Charcot-Marie-Tooth Disease
7,577 Patients Enrolled for Charcot-Marie-Tooth Disease
Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER
62 Previous Clinical Trials
308,594 Total Patients Enrolled
2 Trials studying Charcot-Marie-Tooth Disease
6,050 Patients Enrolled for Charcot-Marie-Tooth Disease
Share this study with friends
Copy Link
Messenger